A double-blind comparison of abecarnil and diazepam in the treatment of uncomplicated alcohol withdrawal

Psychopharmacology

Volumn 131, Issue 2, 1997, Pages 123-129

  Anton, Raymond F ^a   Kranzler, Henry R ^b   McEvoy, Joseph P ^c   Moak, Darlene H ^a   Bianca, Ralph ^d  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c John Umstead Hospital   (United States)

^d Sandoz Pharma Ltd   (Switzerland)

Author keywords

Abecarnil; Alcohol withdrawal; Partial benzodiazepine agonists; Treatment

Indexed keywords

ABECARNIL; ALCOHOL; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; BETA CARBOLINE DERIVATIVE; DIAZEPAM; LIVER ENZYME;

ADULT; ALCOHOL BLOOD LEVEL; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WITHDRAWAL SYNDROME;

ADULT; ALCOHOLISM; ANTI-ANXIETY AGENTS; CARBOLINES; DIAZEPAM; DOUBLE-BLIND METHOD; HUMANS; MALE; MIDDLE AGED; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0030962513     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050274     Document Type: Article

References (34)

1. Anton RF, Becker HC (1995) Pharmacotherapy and pathophysiology of alcohol withdrawal. In: Kranzler HR (ed) The pharmacology of alcohol abuse. Springer, New York, pp 315-367
2. Ballenger JC, Post RM (1978) Kindling as a model for alcohol withdrawal syndromes. Br J Psychiatry 133:1-14
3. Baumgartner GR, Rowen RC (1987) Clonidine vs. chlordiazepoxide in the management of acute alcohol withdrawal syndrome. Arch Int Med 147:1223-1226
4. Becker HC (1994) Positive relationship between the number of prior ethanol withdrawal episodes and the severity of subsequent withdrawal seizures. Psychopharmacology 116:26-32
5. Becker HC, Hale RL (1993) Repeated episodes of ethanol withdrawal potentiate the severity of subsequent withdrawal seizures: an animal model of alcohol withdrawal "kindling". Alcohol Clin Exp Res 17:94-98
6. Brown ME, Anton RF, Malcolm R, Ballenger JC (1988) Alcohol detoxification and withdrawal seizures: clinical support for a kindling hypothesis. Biol Psychiatry 23: 507-514
7. Castaneda R, Cushman P (1989) Alcohol withdrawal: a review of clinical management. J Clin Psychiatry 50:278-284
8. Crabbe JC (1992) Antagonism of ethanol withdrawal convulsions in withdrawal seizure prone mice by diazepam and abecarnil. Eur J Pharmacol 221:85-90
9. Duka T, Schutt B, Krause W, Dorow R, McDonald S, Fichte K (1993) Human studies on abecarnil, a new beta-carboline anxiolytic: safety, tolerability and preliminary pharmacological profile. Br J Clin Pharmacol 35:386-394
10. Friedman LM, Keck PE Jr, Bianca R, Cutler NR, Cole JO (1993) A prospective, double-blind, randomized, cross-over, outpatient study to evaluate and compare the subjective effects of placebo, abecarnil, and diazepam in volunteer adults with a history of recreational sedative drug use. NCDEU Meeting, Marco Island, Fla.
11. Jaffe JH, Ciraulo DA, Nies A, Dixon RB, Monroe LL (1983) Abuse potential of halazepam and of diazepam in patients recently treated for acute alcohol withdrawal. Clin Pharmacol Ther 34:623-630
12. Lechtenberg R, Worner TM (1991) Relative kindling effect of detoxification and non-detoxification admissions in alcoholics. Alcohol Alcohol 26:221-225
13. Loscher W, Rundfeldt C, Honack D (1991) Tolerance to anticonvulsant effects of the partial benzodiazepine receptor agonist abecarnil in kindled rats involves learning. Eur J Pharmacol 202:303-310
14. Malcolm RJ, Sturgis E, Ballenger JC, Anton RF (1989) A double-blind trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal. Am J Psychiatry 146:617-621
15. McLellan AT, Luborsky L, Woody GE, O'Brien CP (1980) An improved diagnostic evaluation instrument for substance abuse patients: the Addiction Severity Index. J Nerv Ment Dis 168:26-33
16. Moskowitz G, Chalmers TC, Sacks HS, Fagerstrom RM, Smith H (1983) Deficiencies of clinical trials of alcohol withdrawal. Alcohol Clin Exp Res 7:42-46
17. Mumford GK, Rush CR, Griffiths RR (1995) Abecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects. J Pharmacol Exp Ther 272:570-580
18. Naranjo CA, Sellers EM, Chater K, Iversen P, Roach C, Sykora K (1983) Nonpharmacologic intervention in acute alcohol withdrawal.Clin Pharmacol Ther 34:214-219
19. Ozawa M, Nakada Y, Sugimachi K, Yabuuchi F, Akai T, Mizuta E, Kuno S, Yamaguchi M (1994a) Pharmacological characterization of the novel anxiolytic beta-carboline abecarnil in rodents and primates. J Pharmacol 64:179-187
20. Ozawa M, Sugimachi K, Nakada-Kometani Y, Akai T, Yamaguchi M (1994b) Chronic pharmacological activities of the novel anxiolytic beta-carboline abecarnil in rats. J Pharmacol Exp Ther 269:457-462
21. Sellers EM, Kalant H (1976) Alcohol intoxication and withdrawal. N Engl J Med 294:757-762
22. Sellers EM, Naranjo CA, Harrison M, Devenyi P, Roach C, Sykora K (1983) Diazepam loading: simplified treatment of alcohol withdrawal. Clin Pharmacol Ther 34:822-926
23. Sellers EM, Sullivan JT, Somer G, Sykora K (1991) Characterization of DSM-III-R criteria for uncomplicated alcohol withdrawal provides an empirical basis for DSM-IV. Arch Gen Psychiatry 48:442-447
24. Serra M, Ghiani CA, Motzo C, Porceddu ML, Biggio G (1994) Long-term treatment with abecarnil fails to induce tolerance in mice. Eur J Pharmacol 259:1-6
25. Shaw GK (1995) Detoxification: the use of benzodiazepines. Alcohol Alcohol 30:765-770
26. Shaw JM, Kolesar GS, Sellers EM, Kaplan HL, Sandors P (1981) Development of optimal treatment tactics for alcohol withdrawal. I. Assessment and effectiveness of supportive care. J Clin Psychopharmacol 1:382-387
27. Skinner HA, Allen BA (1982) Alcohol dependence syndrome: measurement and validation (1982) J Abnorm Psychol 91:199-209
28. Sobell LC, Sobell MB, Leo CI, Cancilla A (1988) Reliability of a timeline method. Assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations. Br J Addic 83:393-402
29. Stephens DN, Schneider HH, Kehr W, Andrews JS, Rettig KJ, Turski L, Schmiechen R, Turner JD, Jensen LH, Petersen EN, Honore T, Hansen JB (1990) Abecarnil, a metabolically stable, anxioselective beta-carboline acting at benzodiazepine receptors. J Pharmacol Exp Ther 253:334-343
30. Steppuhn KG, Schneider HH, Turski L, Stephens DN (1993) Long-term treatment with abecarnil does not induce diazepam-like dependence in mice. J Pharmacol Exp Ther 264:1395-1400
31. Stuppaeck CH, Pycha R, Miller C, Whitworth AB, Oberbauer H, Fleischhacker WW (1992) Carbamazepine versus oxazepam in the treatment of alcohol withdrawal: a double-blind study. Alcohol Alcohol 27:153-158
32. Sullivan JT, Swift RM, Lewis DC (1989) Assessment of alcohol withdrawal: the revised Clinical Institute Withdrawal Assessment for Alcohol Scale (CIWA-Ar). Br J Addict 84:1353-1357
33. Sullivan JT, Swift RM, Lewis DC (1991) Benzodiazepine requirements during alcohol withdrawal syndrome: clinical implications of using a standardized withdrawal scale. J Clin Psychopharmacol 11:291-295
34. Turski L, Stephens DN, Jensen LH, Petersen EN, Meldrum BS, Patel S, Hansen JB, Loscher W, Schneider HH, Schmiechen R (1990) Anticonvulsant action of the beta-carboline abecarnil: studies in rodents and baboon, Papio papio. J Pharmacol Exp Ther 25:344-352